Share on StockTwits

Semler Scientific (NASDAQ:SMLR) Director Herbert J. Semler sold 30,000 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $3.50, for a total value of $105,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Semler Scientific (NASDAQ:SMLR) traded down 0.67% during mid-day trading on Thursday, hitting $3.566. The stock had a trading volume of 7,116 shares. Semler Scientific has a one year low of $2.75 and a one year high of $7.25. The stock’s 50-day moving average is $3.59 and its 200-day moving average is $4.66. The company’s market cap is $16.8 million.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Friday, July 25th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.03. Analysts expect that Semler Scientific will post $-0.98 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Aegis downgraded shares of Semler Scientific from a “buy” rating to a “hold” rating in a research note on Monday, July 28th.

Semler Scientific, Inc is a medical risk-assessment company. The Company develops, manufactures and markets patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services.

Receive News & Ratings for Semler Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.